News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3125last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Investing.com4d agobullish
European shares gain on Novo’s results; markets weigh U.S. midtermsThe Wall Street Journal4d agoneutral
Novo Nordisk Lifts Guidance as Rollout of Wegovy Weight-Loss Pill ContinuesGuruFocus.com5d agoneutral
Earnings To Watch: Novo Nordisk AS (NVO) Q3 2026 -- GF Value Sees 146% UpsideSimply Wall St.6d agoneutral
Novo Nordisk (CPSE:NOVO B) Set To Unveil New Obesity Data At ObesityWeek 2026Motley Fool6d agoneutral
Here's Why I Think Every Investor Needs to Invest in These "Miracle" DrugsGlobeNewswire6d agoneutral
GENFIT to Highlight Progress in ACLF and MASH Diagnostics at AASLD The Liver Meeting® 2026Simply Wall St.9d agoneutral
Novo Nordisk (NYSE:NVO) Could Be 61% Undervalued Following Rising GLP 1 Competition24/7 Wall St.9d agoneutral
Eli Lilly’s Next Trillion-Dollar Opportunity May Go Beyond Weight-Loss Drugs